Emapalumab-Lzsg Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 10 mg/2 mL, 50 mg/10 mL
Reference Brands: Gamifant (USA/EU)
Category: Orphan Drugs
Emapalumab-lzsg is a fully human monoclonal antibody that binds and neutralizes interferon-gamma (IFN-γ), helping to suppress excessive immune activation. It is used in patients with hemophagocytic lymphohistiocytosis (HLH), a rare and life-threatening hyperinflammatory syndrome. By inhibiting IFN-γ activity, it helps restore immune balance in patients unresponsive or intolerant to conventional treatments such as corticosteroids, etoposide, or cyclosporine. Emapalumab-lzsg is available in Injection and strengths such as 10 mg/2 mL, 50 mg/10 mL. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Emapalumab-lzsg is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Emapalumab-lzsg can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Emapalumab-lzsg is used to treat primary hemophagocytic lymphohistiocytosis (HLH) in adults and children who have not responded to conventional therapy. It helps control excessive immune activation by blocking interferon gamma, a key inflammatory cytokine involved in the disease.
Emapalumab-lzsg is made from the active ingredient emapalumab-lzsg, a recombinant human monoclonal antibody that specifically binds to and neutralizes interferon gamma, reducing the severe inflammation and immune system overactivity seen in HLH.
Emapalumab-lzsg is marketed under the trade name Gamifant.
Emapalumab-lzsg is manufactured by Sobi (Swedish Orphan Biovitrum AB).
The generic name of Emapalumab-lzsg is Emapalumab-lzsg.
The brand name of Emapalumab-lzsg is Gamifant.
Emapalumab-lzsg is manufactured in the United States and Sweden by Sobi (Swedish Orphan Biovitrum AB) and its authorized production partners.
Related Products
Arimoclomol
Strength:
47 mg, 62mg, 93mg
Form: Capsules
Reference Brands: MIPLYFFA (USA)
View Details
Doxecitine + Doxribtimine
Strength:
2g+2g
Form: Oral Solution
Reference Brands: Kygevvi (USA)
View Details
Migalastat Hydrochloride
Strength:
123 mg
Form: Capsules
Reference Brands: Galafold (USA/EU)
View Details
Quick Response Guaranteed | Verified Suppliers
